Replies to post #233746 on Biotech Values

[DewDiligence]

PFE/BNTX may have a slight edge versus MRNA at this point, but that’s far from clear-cut.

[biocqr]

Re: MRNA vs Pfizer/BioNTech: Derek Lowe analyzes the Pfizer data with comparisons to Moderna's...

More Pfizer Phase I Results: Antibodies, Viral Mutations, and T Cells

https://blogs.sciencemag.org/pipeline/archives/2020/07/20/more-pfizer-phase-i-results-antibodies-viral-mutations-and-t-cells

I noted in the earlier post that Moderna’s neutralizing antibody data looked best at Day 43, and then went down a bit. These Pfizer/BioNTech numbers look best at Day 29, and have gone down a bit at Day 43. The effect is not huge, but it’s real. The text of the paper says “still increasing up to Day 43”, but that’s not what I see in Figure 2, and I don’t think I would have used that language, myself.


the T cell response looks promising (and probably better than the Moderna candidate)